Riccardo Marconcini Luca Galli Andrea Antonuzzo Simona Bursi Claudia Roncella Gabriella Fontanini Elisa Sensi Alfredo Falcone
10.1186/s40164-017-0067-4
Exp Hematol Oncol
2017 Mar 21;6:6.
braf k601e mutation complete response melanoma trametinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/28344857/
Case Reports
PMC5361706
28344857
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months
2017